rss
BMJ Case Reports 2012; doi:10.1136/bcr.02.2012.5797
  • Unexpected outcome (positive or negative) including adverse drug reactions

Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80

  1. Giovanni Rolla1
  1. 1Allergy and Clinical Immunology, University of Torino and AO Ordine Mauriziano, Torino, Italy
  2. 2Laboratory of Immunopathology, AO Ordine Mauriziano of Torino, Torino, Italy
  1. Correspondence to Professor Giovanni Rolla, grolla{at}mauriziano.it

Summary

A 17-year-old girl reported generalised urticaria, eyelid angioedema, rhino-conjunctivitis, dyspnoea and wheezing 1 h after third intramuscular administration of quadrivalent human papilloma virus vaccine (Gardasil). She was treated with antihistamine, and corticosteroids with prompt relief of rhinitis and dyspnoea, while urticaria and angioedema lasted 24 h. Intradermal test with Gardasil, which contains polysorbate 80 (PS80), resulted positive, while skin tests with the bivalent vaccine were negative. Prick test performed with PS80 resulted positive in the patient and negative in ten healthy controls. The CD203 basophil activation test result was negative for PS80 at all the tested dilutions and specific IgE was not found. As flu vaccine was recommended, the authors skin tested two flu vaccine, one containing PS80 (Fluarix, GSK), which resulted positive and another flu vaccine with no adjuvant or preservative (Vaxigrip, Sanofi Pasteur MSD), which gave negative results. The patient then received Vaxigrip without adverse reactions.

Footnotes

  • Competing interests None.

  • Patient consent Obtained.

Top rated cases

Top rated cases

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

 

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog